CRDF ▲ +5.3% - Cardiff Oncology, Inc.
$CRDF - Cardiff Oncology Receives FDA Orphan Drug Designation for Onvansertib in Chronic Myelomonocytic Leukemia
21-OCT-2026 04:05 PM ET
Share this post
More filings for $CRDF
CRDF ▼ -4.1% - Cardiff Oncology, Inc.Sep 14, 2026CRDF ▼ -3.9% - Cardiff Oncology, Inc.Sep 2, 2026$CRDF SEC Filing Update (27-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 27, 2026
View full $CRDF filing history →💬 Comments
Loading comments…
Leave a comment